BIOFRONTERA AG American Depositary Shares - Sponsored

YTD

ALL

Why Robinhood?

You can watch BFAGY and buy or sell other stocks, ETFs, and their options commission-free!

About BFAGY

Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos.

CEO

Hermann Lübbert, PhD

CEOHermann Lübbert, PhD

Employees

—

Employees—

Headquarters

Leverkusen, Nordrhein-Westfalen

HeadquartersLeverkusen, Nordrhein-Westfalen

Founded

1997

Founded1997

Employees

—

Employees—

BFAGY Key Statistics

Market cap

70.33M

Market cap70.33M

Price-Earnings ratio

5.41

Price-Earnings ratio5.41

Dividend yield

—

Dividend yield—

Average volume

2.42K

Average volume2.42K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.89

52 Week high$6.89

52 Week low

$1.50

52 Week low$1.50

BFAGY News

TipRanks 2d

Biofrontera Sets 2026 Guidance and Highlights Growing U.S. Earn-Out Income

The latest announcement is out from Biofrontera ( (DE:B8FK) ). Biofrontera AG has issued financial guidance for 2026, forecasting sales revenue of EUR 14 milli...

TipRanks 3d

Biofrontera reports Phase 2b results of Ameluz PDT in acne vulgaris

Biofrontera (BFRI) announced results of its Phase 2b clinical trial evaluating Ameluz topical gel, 10% PDT for the treatment of moderate to severe acne vulgaris...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.